cannabis report with qcq1 quality control result biased high. only non-detect samples reported. q2...

12
12423 NE Whitaker Way Portland, OR 97230 503-254-1794 Report Number: Report Date: ORELAP#: 12/24/2019 OR100028 10:25 Received: 12/17/19 Purchase Order: 19-015330/D02.R00 Product identity: KS-2019-339-TSO Client/Metrc ID: Terpsolate Customer: 12/16/19 13:08 Sample Date: 19-015330-0001 Laboratory ID: Klersun Summary Potency: 96.0% CBD-Total < 0.178% THC-Total (Reported in percent of total sample) CBD CBDV Analyte Result (%) 96.0 CBD 0.483 CBDV Terpenes: Analyte Percent by weight Percent of Total Analyte Percent by weight Percent of Total 0.568 farnesene 42.71% 0.293 a-Bisabolol 22.03% 0.240 (-)-Guaiol 18.05% 0.0809 ß-Caryophyllene 6.08% 0.0543 (-)-caryophyllene oxide 4.08% 0.0497 Humulene 3.74% 0.0453 (±)-trans-Nerolidol 3.41% 1.33 Total Terpenes 100.00% Page 1 of 12 Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unless otherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unless prior arrangements have been made. Testing in accordance with: OAR 333-007-0430

Upload: others

Post on 13-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Product identity: KS-2019-339-TSO

Client/Metrc ID: Terpsolate

Customer:

12/16/19 13:08Sample Date:19-015330-0001Laboratory ID:

Klersun

SummaryPotency:

96.0%CBD-Total

< 0.178%THC-Total

(Reported in percent of total sample)

CBD

CBDV

Analyte Result (%)96.0CBD

0.483CBDV†

Terpenes:

Analyte Percentby weight

Percentof Total

Analyte Percentby weight

Percentof Total

0.568farnesene† 42.71% 0.293a-Bisabolol† 22.03%

0.240(-)-Guaiol† 18.05% 0.0809ß-Caryophyllene† 6.08%

0.0543(-)-caryophyllene oxide† 4.08% 0.0497Humulene† 3.74%

0.0453(±)-trans-Nerolidol† 3.41% 1.33Total Terpenes† 100.00%

Page 1 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 2: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Customer: Klersun3448 NE Broadway StPortland Oregon 97232United States

Product identity: KS-2019-339-TSO

12/16/19 13:08Sample Date:

19-015330-0001Laboratory ID:

Client/Metrc ID: Terpsolate

Received By MailRelinquished by:

15.7 °CTemp:

Sample ResultsPotency Batch 1911617Method J AOAC 2015 V98-6 Units % Analyze 12/21/19 04:55 AMAnalyte As

ReceivedDryweight

LOQ Notes

< LOQCBC† 0.0951

< LOQCBC-A† 0.0951

< LOQCBC-Total† 0.178

96.0CBD 0.951

< LOQCBD-A 0.0951

96.0CBD-Total 1.03

0.483CBDV† 0.0951

< LOQCBDV-A† 0.0951

0.483CBDV-Total† 0.177

< LOQCBG† 0.0951

< LOQCBG-A† 0.0951

< LOQCBG-Total† 0.177

< LOQCBL† 0.0951

< LOQCBN 0.0951

< LOQ∆8-THC† 0.0951

< LOQ∆9-THC 0.0951

< LOQTHC-A 0.0951

< LOQTHC-Total 0.178

< LOQTHCV† 0.0951

< LOQTHCV-A† 0.0951

< LOQTHCV-Total† 0.177

CBD

CBDV

Page 2 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 3: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Terpenes Batch 1911443Method J AOAC 2015 V98-6 Units % Analyze 12/17/19 06:14 PM

LOQAnalyte Result Notes% of Total LOQAnalyte Result Notes% of Total

0.568farnesene† 42.71%0.020 0.293a-Bisabolol† 22.03%0.020

0.240(-)-Guaiol† 18.05%0.020 0.0809ß-Caryophyllene† 6.08%0.020

0.0543(-)-caryophyllene oxide† 4.08%0.020 0.0497Humulene† 3.74%0.020

0.0453(±)-trans-Nerolidol† 3.41%0.020 < LOQ(-)-a-Terpineol† 0.00%0.020

< LOQ(-)-Isopulegol† 0.00%0.020 < LOQ(-)-ß-Pinene† 0.00%0.020

< LOQ(+)-Borneol† 0.00%0.020 < LOQ(+)-Cedrol† 0.00%0.020

< LOQ(+)-fenchol† 0.00%0.020 < LOQ(+)-Pulegone† 0.00%0.020

< LOQ(±)-Camphor† 0.00%0.020 < LOQ(±)-cis-Nerolidol† 0.00%0.020

< LOQ(±)-fenchone† 0.00%0.020 < LOQ(R)-(+)-Limonene† 0.00%0.020

< LOQa-cedrene† 0.00%0.020 < LOQa-phellandrene† 0.00%0.020

< LOQa-pinene† 0.00%0.020 < LOQa-Terpinene† 0.00%0.020

< LOQCamphene† 0.00%0.020 < LOQcis-ß-Ocimene† 0.00%0.006

< LOQd-3-Carene† 0.00%0.020 < LOQEucalyptol† 0.00%0.020

< LOQgamma-Terpinene† 0.00%0.020 < LOQGeraniol† 0.00%0.020

< LOQGeranyl acetate† 0.00%0.020 < LOQIsoborneol† 0.00%0.020

< LOQLinalool† 0.00%0.020 < LOQMenthol† 0.00%0.020

< LOQnerol† 0.00%0.020 < LOQp-Cymene† 0.00%0.020

< LOQSabinene† 0.00%0.020 < LOQSabinene hydrate† 0.00%0.020

< LOQß-Myrcene† 0.00%0.020 < LOQTerpinolene† 0.00%0.020

< LOQtrans-ß-Ocimene† 0.00%0.013 < LOQvalencene† 0.00%0.020

Total Terpenes 1.33

farn

esen

e

a-B

isab

olol

(-)-

Gua

iol

ß-C

aryo

phyl

lene

(-)-

cary

ophy

llene

ox

ide

Hum

ulen

e

(±)-

tran

s-N

erol

idol

%

Page 3 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 4: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

42.71 %farnesene

22.03 %a-Bisabolol

18.05 %(-)-Guaiol

6.08 %ß-Caryophyllene

4.08 %(-)-caryophyllene oxide

3.74 %Humulene

3.41 %(±)-trans-Nerolidol

Page 4 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 5: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

These test results are representative of the individual sample selected and submitted by the client.

AbbreviationsLimits: Action Levels per OAR-333-007-0400, OAR-333-007-0210, OAR-333-007-0220Limit(s) of Quantitation (LOQ): The minimum levels, concentrations, or quantities of a target variable (e.g., target analyte) that can be

reported with a specified degree of confidence.

† = Analyte not NELAP accredited.

Units of Measure

% = Percentage of sample

% wt = µg/g divided by 10,000

Derrick TannerGeneral Manager

Approved Signatory

Page 5 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 6: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Page 6 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 7: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Page 7 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 8: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

EPA 5035 Batch ID:Method Blank Laboratory Control SampleAnalyte Notes Result LCS Spike Units LCS % Rec Notesa-pinene < 200 541 500 µg/g 108.3 70 - 130Camphene < 200 428 500 µg/g 85.6 70 - 130Sabinene < 200 541 500 µg/g 108.1 70 - 130b-Pinene < 200 539 500 µg/g 107.8 70 - 130b-Myrcene < 200 440 500 µg/g 87.9 70 - 130a-phelllandrene < 200 432 500 µg/g 86.4 70 - 130d-3-Carene < 200 417 500 µg/g 83.5 70 - 130a-Terpinene < 200 541 500 µg/g 108.2 70 - 130p-Cymene < 200 431 500 µg/g 86.3 70 - 130D-Limonene < 200 536 500 µg/g 107.1 70 - 130Eucalyptol < 200 437 500 µg/g 87.5 70 - 130b-cis-Ocimene < 66.7 136 167 µg/g 81.5 70 - 130b-trans-Ocimene < 133 320 333 µg/g 96.1 70 - 130g-Terpinene < 200 580 500 µg/g 116.1 70 - 130Sabinene_Hydrate < 200 559 500 µg/g 111.7 70 - 130Terpinolene < 200 538 500 µg/g 107.6 70 - 130D-Fenchone < 200 534 500 µg/g 106.8 70 - 130Linalool < 200 420 500 µg/g 84.0 70 - 130Fenchol < 200 539 500 µg/g 107.9 70 - 130Camphor < 200 447 500 µg/g 89.5 70 - 130Isopulego < 200 435 500 µg/g 87.0 70 - 130Isoborneol < 200 448 500 µg/g 89.5 70 - 130Borneol < 200 553 500 µg/g 110.5 70 - 130DL-Menthol < 200 437 500 µg/g 87.5 70 - 130Terpineol < 200 523 500 µg/g 104.6 70 - 130Nerol < 200 433 500 µg/g 86.5 70 - 130Pulegone < 200 553 500 µg/g 110.6 70 - 130Gereniol < 200 532 500 µg/g 106.3 70 - 130Geranyl_Acetate < 200 439 500 µg/g 87.8 70 - 130a-Cedrene < 200 528 500 µg/g 105.5 70 - 130b-Caryophyllene < 200 439 500 µg/g 87.7 70 - 130a-Humulene < 200 547 500 µg/g 109.4 70 - 130Valenene < 200 465 500 µg/g 93.0 70 - 130cis-Nerolidol < 200 449 500 µg/g 89.9 70 - 130a-Farnesene < 200 612 500 µg/g 122.4 70 - 130trans-Nerolidol < 200 554 500 µg/g 110.9 70 - 130Caryophyllene_Oxide < 200 439 500 µg/g 87.8 70 - 130Guaiol < 200 564 500 µg/g 112.8 70 - 130Cedrol < 200 448 500 µg/g 89.6 70 - 130a-Bisabolol < 200 447 500 µg/g 89.3 70 - 130

Laboratory Terpene Quality Control Results1911443

Blank LimitsResultNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND

NDND

NDNDNDNDND

ND

NDNDNDNDNDND

NDND

NDNDND

NDNDND

Page 8 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 9: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Sample/Sample Duplicate Sample ID:Analyte Result Org. Result LOQ Units RPD, % Notesa-pinene 1962 1631 200 µg/g 9.21 < 20 80 - 120Camphene 228.5 ND 200 µg/g 0 < 20 80 - 120Sabinene ND ND 200 µg/g 0 < 20 80 - 120b-Pinene 1417 1184 200 µg/g 8.96 < 20 80 - 120b-Myrcene 7369 6158 200 µg/g 8.95 < 20 80 - 120a-phelllandrene ND ND 200 µg/g 0 < 20 80 - 120d-3-Carene ND ND 200 µg/g 0 < 20 80 - 120a-Terpinene ND ND 200 µg/g 0 < 20 80 - 120p-Cymene ND ND 200 µg/g 0 < 20 80 - 120D-Limonene 16980 14240 200 µg/g 8.78 < 20 80 - 120Eucalyptol ND ND 200 µg/g 0 < 20 80 - 120b-cis-Ocimene 119.5 96.4 66.7 µg/g 10.7 < 20 80 - 120b-trans-Ocimene 1578 1304 133 µg/g 9.51 < 20 80 - 120g-Terpinene ND ND 200 µg/g 0 < 20 80 - 120Sabinene_Hydrate ND ND 200 µg/g 0 < 20 80 - 120Terpinolene 2076 1737 200 µg/g 8.89 < 20 80 - 120D-Fenchone ND ND 200 µg/g 0 < 20 80 - 120Linalool 1116 913.2 200 µg/g 10 < 20 80 - 120Fenchol 1438 1191 200 µg/g 9.40 < 20 80 - 120Camphor ND ND 200 µg/g 0 < 20 80 - 120Isopulego ND ND 200 µg/g 0 < 20 80 - 120Isoborneol ND ND 200 µg/g 0 < 20 80 - 120Borneol 353.6 300.5 200 µg/g 8.12 < 20 80 - 120DL-Menthol ND ND 200 µg/g 0 < 20 80 - 120Terpineol 1108 917.8 200 µg/g 9.39 < 20 80 - 120Nerol ND ND 200 µg/g 0 < 20 80 - 120Pulegone ND ND 200 µg/g 0 < 20 80 - 120Gereniol ND ND 200 µg/g 0 < 20 80 - 120Geranyl_Acetate ND ND 200 µg/g 0 < 20 80 - 120a-Cedrene ND ND 200 µg/g 0 < 20 80 - 120b-Caryophyllene 29850 24760 200 µg/g 9.32 < 20 80 - 120a-Humulene 11660 9811 200 µg/g 8.61 < 20 80 - 120Valenene ND ND 200 µg/g 0 < 20 80 - 120cis-Nerolidol ND ND 200 µg/g 0 < 20 80 - 120a-Farnesene 25250 20070 200 µg/g 11.4 < 20 80 - 120trans-Nerolidol 323.8 321.9 200 µg/g 0.29 < 20 80 - 120Caryophyllene_Oxide 618.1 501.7 200 µg/g 10.4 < 20 80 - 120Guaiol ND ND 200 µg/g 0 < 20 80 - 120Cedrol ND ND 200 µg/g 0 < 20 80 - 120a-Bisabolol 7336 6130 200 µg/g 8.96 < 20 80 - 120

Sample Duplicate % Limits19-015204-0001

Page 9 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 10: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Revision #: 0.00 Control : CFL-D06Revision Date: 05/31/2019 Effective Date: 05/31/2019

J AOAC 2015 V98-6 Batch ID:Laboratory Control SampleAnalyte Result Spike Units % Rec Evaluation Notes

CBDV-A 0.204 0.2 102 85.0 - 115 Acceptable

CBDV 0.207 0.2 103 85.0 - 115 Acceptable

CBD-A 0.204 0.2 102 85.0 - 115 Acceptable

CBG-A 0.207 0.2 103 85.0 - 115 Acceptable

CBG 0.205 0.2 103 85.0 - 115 Acceptable

CBD 0.198 0.2 99.1 85.0 - 115 Acceptable

THCV 0.200 0.2 100 85.0 - 115 Acceptable

THCVA 0.198 0.2 99.1 85.0 - 115 Acceptable

CBN 0.195 0.2 97.3 85.0 - 115 Acceptable

THC 0.196 0.2 98.2 85.0 - 115 Acceptable

D8THC 0.206 0.2 103 85.0 - 115 Acceptable

CBL 0.196 0.2 98.2 85.0 - 115 Acceptable

CBC 0.208 0.2 104 85.0 - 115 Acceptable

THCA 0.187 0.2 93.7 85.0 - 115 Acceptable

CBCA 0.200 0.2 99.9 85.0 - 115 Acceptable

Method BlankAnalyte Result LOQ Units Evaluation Notes

CBDV-A <LOQ 0.1 < Acceptable

CBDV <LOQ 0.1 < Acceptable

CBD-A <LOQ 0.1 < Acceptable

CBG-A <LOQ 0.1 < Acceptable

CBG <LOQ 0.1 < Acceptable

CBD <LOQ 0.1 < Acceptable

THCV <LOQ 0.1 < Acceptable

THCVA <LOQ 0.1 < Acceptable

CBN <LOQ 0.1 < Acceptable

THC <LOQ 0.1 < Acceptable

D8THC <LOQ 0.1 < Acceptable

CBL <LOQ 0.1 < Acceptable

CBC <LOQ 0.1 < Acceptable

THCA <LOQ 0.1 < Acceptable

CBCA <LOQ 0.1 < Acceptable

AbbreviationsND - None Detected at or above MRL

RPD -Relative Percent Difference

LOQ - Limit of Quantitation

Units of Measure:

% - Percent

% 0.1

% 0.1

0.1

0.1

0.1

%

%

0.1

%

%

%

%

%

0.1%

%

%

%

% 0.1

0.1

0.1

% 0.1

% 0.1

0.1

Laboratory Quality Control Results1911617

Limits

%

%

%

%

%

%

%

%

%

0.1

%

Limits

%

%

%

%

0.1

Page 10 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 11: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Revision #: 0.00 Control : CFL-D06Revision Date: 05/31/2019 Effective Date: 05/31/2019

Laboratory Quality Control ResultsJ AOAC 2015 V98-6 Batch ID:Sample Duplicate Sample ID:

Analyte Result Org. Result LOQ Units RPD Evaluation Notes

CBDV-A <LOQ <LOQ 0.1 NA < Acceptable

CBDV <LOQ <LOQ 0.1 NA < Acceptable

CBD-A 0.150 0.171 0.1 13.7 < Acceptable

CBG-A 1.39 1.60 0.1 14.4 < Acceptable

CBG 0.177 0.203 0.1 13.5 < Acceptable

CBD <LOQ <LOQ 0.1 NA < Acceptable

THCV <LOQ <LOQ 0.1 NA < Acceptable

THCVA 0.238 0.236 0.1 0.770 < Acceptable

CBN <LOQ <LOQ 0.1 NA < Acceptable

THC 0.494 0.596 0.1 18.8 < Acceptable

D8THC <LOQ <LOQ 0.1 NA < Acceptable

CBL <LOQ <LOQ 0.1 NA < Acceptable

CBC <LOQ <LOQ 0.1 NA < Acceptable

THCA 85.7 79.9 0.1 7.04 < Acceptable

CBCA 1.13 1.26 0.1 11.5 < Acceptable

AbbreviationsND - None Detected at or above MRL

RPD -Relative Percent Difference

LOQ - Limit of Quantitation

NA - Calculation Not Applicable given non-numerical results

Units of Measure:

% - Percent

% 20

% 20

% 20

%

19-015204-0006

% 20

% 20

20

1911617

% 20

% 20

Limits

% 20

% 20

% 20

% 20

20

% 20

%

% 20

Page 11 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430

Page 12: Cannabis Report with QCQ1 Quality control result biased high. Only non-detect samples reported. Q2 Quality control outside QC limits. Data considered estimate. Q3 Sample concentration

12423 NE Whitaker WayPortland, OR 97230

503-254-1794

Report Number:

Report Date:

ORELAP#:

12/24/2019

OR100028

10:25Received: 12/17/19

Purchase Order:

19-015330/D02.R00

Code Explanation

Q Matrix interferences affecting spike or surrogate recoveries.

Q1 Quality control result biased high. Only non-detect samples reported.

Q2 Quality control outside QC limits. Data considered estimate.

Q3 Sample concentration greater than four times the amount spiked.

Q4 Non-homogenous sample matrix, affecting RPD result and/or % recoveries.

Q5 Spike results above calibration curve.

Q6 Quality control outside QC limits. Data acceptable based on remaining QC.

R Relative percent difference (RPD) outside control limit.

R1 RPD non-calculable, as sample or duplicate results are less than five times the LOQ.

R2 Sample replicates RPD non-calculable, as only one replicate is within the analytical range.

LOQ1 Quantitation level raised due to low sample volume and/or dilution.

LOQ2 Quantitaion level raised due to matrix interference.

B Analyte detected in method blank, but not in associated samples.

B1 The sample concentration is greater than 5 times the blank concentration.

B2 The sample concentration is less than 5 times the blank concentration.

Explanation of QC Flag Comments:

Page 12 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.

Testing in accordance with: OAR 333-007-0430